Inogen (NASDAQ:INGN) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.28) by 50 percent. This is a 27.27 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $85.109 million which beat the analyst consensus estimate of $82.350 million by 3.35 percent. This is a 3.44 percent increase over sales of $82.280 million the same period last year.